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Is Shared by Populations of African and European Descent
Teresa R. de Candia,1,2,* S. Hong Lee,3 Jian Yang,3,4 Brian L. Browning,5 Pablo V. Gejman,6
Douglas F. Levinson,7 Bryan J. Mowry,3,8 John K. Hewitt,1,2 Michael E. Goddard,9,10
Michael C. O’Donovan,11 Shaun M. Purcell,12 Danielle Posthuma,13,14,15 the International
Schizophrenia Consortium,16 the Molecular Genetics of Schizophrenia Collaboration,16
Peter M. Visscher,3,4 Naomi R. Wray,3,17 and Matthew C. Keller1,2,17,*
To investigate the extent to which the proportion of schizophrenia’s additive genetic variation tagged by SNPs is shared by populations
of European and African descent, we analyzed the largest combined African descent (AD [n ¼ 2,142]) and European descent (ED
[n ¼ 4,990]) schizophrenia case-control genome-wide association study (GWAS) data set available, the Molecular Genetics of
Schizophrenia (MGS) data set. We show how a method that uses genomic similarities at measured SNPs to estimate the additive genetic
correlation (SNP correlation [SNP-rg]) between traits can be extended to estimate SNP-rg for the same trait between ethnicities. We
estimated SNP-rg for schizophrenia between the MGS ED and MGS AD samples to be 0.66 (SE ¼ 0.23), which is significantly different
from 0 (p(SNP-rg ¼ 0) ¼ 0.0003), but not 1 (p(SNP-rg ¼ 1) ¼ 0.26). We re-estimated SNP-rg between an independent ED data set
(n ¼ 6,665) and the MGS AD sample to be 0.61 (SE ¼ 0.21, p(SNP-rg ¼ 0) ¼ 0.0003, p(SNP-rg ¼ 1) ¼ 0.16). These results suggest that
many schizophrenia risk alleles are shared across ethnic groups and predate African-European divergence.
Introduction
Schizophrenia is a severe mental disorder with a lifetime
prevalence around 1% and a heritability of 0.7–0.8.1,2
Using a linear mixed model, we previously found that
about a third of the genetic variation in liability to schizo-
phrenia is captured by additive effects of common (minor
allele frequency [MAF] > 0.01) SNPs in a large European
case-control data set.3 This approach first derives genetic
similarities at measured SNPs among classically unrelated
individuals and then uses those similarities to estimate
the amount of variability explained by all SNPs together.
Because rare causal variants are not well predicted by com-
mon SNPs, this finding suggests that a substantial portion
of the heritability of schizophrenia is due to additive
effects of common causal variants,3 a conclusion consistent
with extrapolations from results by a different meth-
odology.4 However, it is unclear whether this result also
applies to populations of African descent and, if so,
whether the proportion of schizophrenia’s genetic varia-
tion tagged by SNPs is shared between populations of
African descent (AD) and European descent (ED). Although
rare variants (MAF< 0.01) are largely population specific,5,6
common variants are typically polymorphic across diver-
gent ethnic groups;7 therefore, it is possible that ameaning-
ful portion of schizophrenia’s genetic variation tagged by
common SNPs could be shared between ED and AD indi-
viduals. However, different causal variants between ethnic-
ities, or different linkage-disequilibrium (LD) patterns
between SNPs and causal variants across ethnicities,
could result in lower overlap in additive genetic variation
tagged by SNPs. To date, ~96% of genome-wide association
study (GWAS) participants have been ED individuals.8,9
Because SNP associations might differ between ethnicities,
genetic studies using European-only samples could yield
results with a strong Eurocentric bias.10
A traditional approach for understanding whether SNP
associations are consistent across ethnicities is to assess
the similarity of GWAS results among different ethnic
groups11–14. However, for most complex traits, only a
small minority of truly associated SNPs reach stringent
genome-wide significance thresholds,15 and so overlap in
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significant associations is not necessarily expected, even if
the effects of most SNPs are similar across ethnicities. In an
attempt to gain insight into the overall consistency of
schizophrenia SNP associations between ED and AD popu-
lations, a previous study4 used extremely liberal p value
thresholds to define large sets of risk-score alleles in LD
in an ED ‘‘discovery’’ sample and used these alleles to
generate risk scores in independent ‘‘target’’ samples (the
Molecular Genetics of Schizophrenia [MGS] ED and AD
samples, as well as the smaller ‘‘O’Donovan’’ ED sample).
The most significantly associated set of SNPs in the ED
discovery sample did predict case-control status in the
AD target sample (p ¼ 0.008) but explained substantially
less variance (R2 ¼ 0.4%) than in the ED target samples
(MGS ED: R2 ¼ 3.2%, p ¼ 2 3 10"28; O’Donovan: R2 ¼
2.3%, p ¼ 5 3 10"11), which might appear to suggest
only modest overlap in schizophrenia SNP associations
between EDs and ADs.
A limitation of the genetic-risk-score approach4,16 is that
it requires accurate estimation of effect sizes of individual
SNPs in the discovery sample, and error variance of
GWAS point estimates accumulates in prediction scores
and thus causes estimates of overlap (R2) to be biased
downward as a function of sample size. Furthermore, the
genetic-risk-score approach can underestimate overlap
between ED and AD populations, in particular when dis-
covery SNPs are pruned to be in LD in an ED discovery
sample: because LD tends to be lower in AD popula-
tions,17 more SNPs are required for predicting causal vari-
ants in AD populations than in ED populations.
In the present study, we used a bivariate linear mixed-
effects model implemented in GCTA18 to estimate the
proportion of schizophrenia-risk variation that is tagged
by the additive effects of SNPs (we refer to this estimate
as the SNP heritability) in predominately AD individuals
(African Americans). We also estimated the additive
genetic correlation tagged by SNPs (the SNP correlation)
in schizophrenia between ED and AD individuals. With
this approach, the effects of SNPs are treated as statistically
random and individual SNP effects are not estimated, nor
is there a need to prune SNPs for LD or statistical sig-
nificance. Rather, all SNPs are used simultaneously for
estimating genome-wide similarities between pairs of
individuals; these similarity estimates are in turn used for
estimating variance and covariance parameters in a linear
mixed-effects model. This method does not depend on
reliable estimation of individual SNP effects and so should
provide unbiased estimates of the SNP heritability and SNP
correlation regardless of subject sample size (larger samples
should decrease the SEs of estimates).
Material and Methods
GWAS Samples and Quality Control
The MGS and International Schizophrenia Consortium (ISC) case-
control data sets have previously been described in detail.3,4,19,20
The study and use of these data sets were approved by institutional
review boards at the University of Colorado. BecauseMGS subjects
and just over half of ISC subjects were genotyped for 909,622
autosomal SNPs (on Affy 6 Platforms), whereas just under half of
ISC subjects were genotyped for ~500K autosomal SNPs on
earlier platforms (Affy 5 and Affy 500K), we used imputed ISC
data to maximize the number of subjects included in the analysis.
Therefore, we conducted the main analysis by using raw MGS and
imputed ISC genotypes. We imputed ISC genotypes with HapMap
3 CEU (Utah residents with ancestry from northern and western
Europe from the CEPH collection) and TSI (Toscani in Italia) pop-
ulations as reference panels.20 We imputed MGS ED genotypes in
the same way to allow a comparison of results from raw and
imputed data. We found no evidence that use of imputed data
affected estimates of SNP heritabilities or SNP correlations;
results were virtually identical across models that used imputed
versus raw MGS ED data (Table S1, available online). We did not
attempt to impute MGS AD genotypes because of the difficulty
of imputing admixed AD samples.21,22 We calculated the MAF
and imputation R2 (ratio of observed to expected variance) for
each SNP for quality-control purposes.
Each data set underwent stringent quality-control procedures
separately. In particular, we dropped (1) individuals with average
missing rates in raw SNP calls > 0.02; (2) individuals who were
more than 5 SDs away from the cohort’s (within data set, within
ethnicity) mean scores on the first two ethnic principal compo-
nents (PCs; see ‘‘PC Analysis’’ below), the first of which differenti-
ated ED and AD individuals; and (3) one individual from each pair
of individuals with genome-wide similarities > 0.05. We dropped
SNPs when (1) MAF < 0.01; (2) missing rates > 0.02 (raw
data only); (3) missing rate differences between cases and
controls > 0.02 (raw data only); (4) SNP frequency differences to
CEU HapMap > 0.15 (because AD individuals tend to be admixed,
the MGS AD data set did not undergo this step); (5) Hardy-
Weinberg equilibrium test (controls only) p < 10"6; and (6) impu-
tation R2 < 0.6 in all cohorts (imputed data only). Only SNPs in
common across cohorts were kept for analysis, resulting in
477,664 SNPs. Final cohort sample sizes are summarized in Table 1.
PC Analysis
PC analysis is used for reducing the dimensionality of data with
correlated variables. When applied to genomic-similarity matrices
computed from SNP data, the first several PCs typically capture
ancestry differences between populations and later PCs can also
capture technical batch effects. We ran PC analysis on subject
pairwise genomic (identity by state [IBS]) similarities across SNPs
from the combined MGS AD, MGS ED, and ISC ED samples, along
with JPT, YRI, and CEU HapMap reference panels, by using a
random subset of 30K SNPs that were pruned to be in linkage
equilibrium and that were shared in common across samples.
The use of HapMap reference panels ‘‘anchored’’ our PC results,
Table 1. Cohort Sizes and Univariate SNP Heritabilities and SEs
Sample Cases Controls h2 (SE)a
MGS AD 1,223 919 0.24 (0.09)
MGS ED 2,571 2,419 0.28 (0.03)
ISC EDb 3,220 3,445 0.27 (0.02)
ah2 represents SNP heritability.
bISC comprises eight imputation cohorts genotyped at separate sites.
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such that the first PC (PC1) distinguished African and European
ancestries and the second distinguished Asian ancestry
(Figure S1). We used the PC results to remove ethnic outliers (see
‘‘GWAS Samples and Quality Control’’ above), for inclusion as
covariates to control for population stratification (see ‘‘Linear
Mixed Models for Estimating Case-Control Status’’ below), and
to divide the MGS AD sample into subsamples on the basis of de-
gree of European admixture. After quality control, ADs were
divided into overlapping subsets of decreasing degrees of Euro-
pean admixture, removing individuals > 2, > 1, and > 0.5 SDs
above the mean AD PC1 score (Figure S1).
Linear Mixed Models for Estimating Case-Control
Status
For univariate heritability models, we estimated genomic similar-
ities between pairs of individuals separately in the MGS AD
sample, in the MGS ED sample, and in the ISC ED sample by
using themethod described by Yang et al.23 In particular, we calcu-
lated the genomic similarity for each pair of individuals by
taking the sum of the products of SNP coefficients between
those individuals and then scaling that sum by the expected
SNP heterozygosity,




















where xil ¼ 0, 1, or 2 according to whether individual i has geno-
type bb, Bb, or BB, respectively, at locus l (alleles are arbitrarily
called b or B), pl and ql are the allele frequencies of B and b, respec-
tively, and 2pl is the mean of xl. These values are scaled to be both
positive and negative; therefore, for clarity we use the term ‘‘simi-
larity’’ rather than ‘‘relationship.’’
For bivariatemodels, we re-estimated the genomic similarities in
the combined MGS AD and MGS ED samples, in the combined
MGS AD and ISC ED samples, and in the combined MGS ED
and ISC ED samples. In the bivariate model, the observed disease
status for traits 1 and 2 can be written as
y1 ¼ X1b1 þ Z1g1 þ e1 for trait 1
y2 ¼ X2b2 þ Z2g2 þ e2 for trait 2;
where y is a vector of observations, b is a vector of fixed covariate
effects, g is a vector of genetic effects tagged by SNPs, and e is a
vector of residuals. X and Z are incidence matrices for b and g,






















where A is the genomic similarity relationship matrix based on
SNP information across all groups, I is an identity matrix, and
s2g, s
2
e , and s
2
g1g2
are genetic variance tagged by SNPs, residual vari-
ance, and covariance between g1 and g2, respectively.
18 We treated
schizophrenia in each sample as a separate ‘‘trait’’ and estimated
SNP heritabilities (h1
2 and h2
2) and the SNP liability covariance
(cov12) or SNP correlation (SNP-rg ¼ cov12/h1h2) between ethnic-
ities.18,23,24 For all models, we transformed genetic-variance esti-
mates to a liability scale by assuming a disease prevalence of 1%,
as described previously,24 and controlled for gender, 20 PCs, and
site (Table 1) as covariates. Although there were large differences
in average similarities of ED-AD pairs compared to within-
ethnicity pairs, we controlled for these differences by including
ancestry PCs as fixed effects, the first of which captured the
African-European gradient (see Figure S1). We also included
PC12 in bivariate models in order to control for any possible ascer-
tainment or diagnostic differences that might exist between the
most and least admixed individuals. For eachmodel, PCs included
as covariates were from an IBS matrix of subjects included in that
model. Because MAFs can vary by ethnicity, for bivariate models,
elements in the A matrix were standardized with expected allele
frequencies that varied by data set.
In the current context, SNP heritability refers to the proportion
of phenotypic variance in liability to schizophrenia that is ex-
plained by the additive effect of all SNPs together, and SNP corre-
lation refers to the additive genetic correlation (explained by all
SNPs together) between the liability of schizophrenia in ADs and
the liability of schizophrenia EDs. Evidence of a SNP correlation
between ADs and EDs occurs to the degree that AD cases are
more genetically similar to ED cases than to ED controls, and
vice versa, after main effects of ethnicity are controlled for.
Because the two traits (schizophrenia in ADs and schizophrenia
in EDs) are measured on different individuals, the only link
between traits is in the genomic-similarity scores for each pair of
individuals. Therefore, unlike traditional (e.g., twin) models that
decompose phenotypic correlations into additive genetic, non-
additive genetic, and environmental sources that can be mutually
confounded, in the present model there is no such confounding,
and SNP correlations are unlikely to be due to residual (e.g.,
environmental or nonadditive genetic) sources.
We used a permutation approach in which affection status was
permuted within ethnicity in order to exclude the possibility of
upward biases of SNP-heritability and SNP-correlation estimates
(see Figure S2). In addition, because prevalence rates have been
shown to vary across populations,25 we varied this parameter
across populations and found that it did not substantially alter
SNP heritabilities or SNP correlations (see Figure S3). That SNP
correlations are unaffected by prevalence-rate differences is also
evident from the transformation equation in Lee et al.18 Also, to
understand whether some of the genetic overlap in schizophrenia
between ED and AD samples might be due to the relatively high
level of European admixture in ADs, estimated to be an average
of ~15%,26 we ran additional bivariate models, each of which
estimated SNP correlations between EDs and AD subsamples of
higher-proportion African ancestry as judged from the first
ancestry PC (see ‘‘PC Analysis’’ above).
We used the likelihood-ratio test statistic to compare the fit of
full models in which SNP correlations were freely estimated to
the fit of reduced models in which SNP correlations were fixed
to either 0 or 1. The distribution of differences in log likelihoods
between full and reduced models is approximately chi-square
distributed with 1 degree of freedom.
Binning SNPs by Rates of Recombination
We examined whether SNPs in regions of high recombination
showed lower SNP correlations than SNPs in regions of low recom-
bination. To do this, we used recombination rates estimated from
CEU, YRI, and JPTþCHB HapMap populations on 3,303,900
SNPs27 and interpolated recombination rates for 476,704 SNPs
in our data sets. For each SNP, an interpolated recombination
rate was derived from a linear regression of recombination rates
on base pair positions for its two closest HapMap neighbors. A
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SNP-correlation estimate was then derived for a model that only
included SNPs with above-median recombination rates and
separately for a second model that only included SNPs with
below-median recombination rates.
Results
We found that the univariate SNP-heritability estimate for
schizophrenia in ADs (h2 ¼ 0.24, SE ¼ 0.09) was slightly
lower than the SNP-heritability estimates in EDs (h2 ¼
0.28, SE ¼ 0.03 in MGS EDs; h2 ¼ 0.27, SE ¼ 0.02 in
ISCs; Table 1), as might be expected given the lower
average LD between SNPs in African populations.17 The
schizophrenia-liability SNP correlation captured by auto-
somal SNPs between the sexes was high (SNP-rg ¼ 0.70)
among ADs, although a strong conclusion is not possible
given the large SE (0.51) around the SNP-rg estimate.
Nevertheless, this estimate is consistent with the be-
tween-sex genetic correlation we previously reported for
schizophrenia in a much larger sample of EDs (SNP-rg ¼
0.89, SE¼ 0.06). To assess whether SNP heritability differed
by functional annotation of SNPs, we partitioned the vari-
ance explained by SNPs into three components by creating
genomic-similarity matrices of SNPs in genes expressed in
the CNS, those found in other genes, and those not local-
ized to genes. The proportion of SNP heritability estimated
from SNPs in genes expressed in the CNS was 30% for ADs,
and although large SEs do not allow us to distinguish
whether this is significantly greater than the 20% of the
genome these SNPs represent (SE ¼ 0.18, p(30% ¼ 20%) ¼
0.30), these results are also consistent with those we re-
ported previously for EDs (31%, SE ¼ 0.02, p(31% ¼ 20%) ¼
7.6 3 10"8; see Table S2).
The main goal of our analysis was to understand the
degree to which genetic variation tagged by SNPs is shared
between ED and AD populations. To do this, we
estimated the SNP correlation (SNP-rg) for schizophrenia
between ethnicities. SNP correlations were estimated
as SNP-rg ¼ 0.66 (SE ¼ 0.23, p(SNP-rg ¼ 0) ¼ 0.0003,
p(SNP-rg ¼ 1) ¼ 0.26) between MGS ADs and MGS EDs and
similarly as SNP-rg ¼ 0.61 (SE ¼ 0.21, p(SNP-rg ¼ 0) ¼
0.0003, p(SNP-rg ¼ 1) ¼ 0.16) between MGS ADs and ISC
EDs. By way of comparison, the SNP correlation between
MGS EDs and ISC EDs was estimated as SNP-rg ¼ 0.83
(SE ¼ 0.09, p(SNP-rg ¼ 0) < 0.0001, p(SNP-rg ¼ 1) ¼ 0.09)
(Table 2). In follow-up analyses, controlling for 6 rather
than 20 PCs made little difference to SNP-heritability or
SNP-correlation estimates (Table S3). By excluding one
chromosome and rerunning these models 22 times, we
found no evidence that any individual chromosome
disproportionately influenced SNP-heritability or SNP-
correlation estimates (Table S4).
Compared to SNPs with low MAF, SNPs with high MAF
typically better tag high-MAF causal variants, which are
more likely to predate the African-European divergence.
We therefore predicted that the genetic correlation
between EDs and ADs would be higher for high-MAF
SNPs than for low-MAF SNPs. Consistent with this
expectation, SNP-correlation estimates derived from
genomic-relationship matrices restricted to SNPs with
above-median MAFs (MAF > 0.26) were higher (SNP-rg ¼
0.79, SE ¼ 0.28, p(SNP-rg ¼ 0) < 0.0001, p(SNP-rg ¼ 1) ¼ 0.52
between MGS ADs and MGS EDs and SNP-rg ¼ 0.67, SE ¼
0.27, p(SNP-rg ¼ 0) ¼ 0.0004, p(SNP-rg ¼ 1) ¼ 0.37 between
MGS ADs and ISC EDs) than SNP-correlation estimates
derived from genomic-relationship matrices restricted to
SNPs with below-median MAFs (MAF < 0.26, SNP-rg ¼
0.34, SE ¼ 0.20, p(SNP-rg ¼ 0) ¼ 0.0706, p(SNP-rg ¼ 1) ¼
0.0399 between MGS ADs and MGS EDs and
SNP-rg ¼ 0.42, SE ¼ 0.18, p(SNP-rg ¼ 0) ¼ 0.0126,
p(SNP-rg ¼ 1) ¼ 0.0321 between MGS ADs and ISC EDs;
Table 3). We observed that SNP heritabilities were lower
for above-median-MAF (h2 ~ 0.13) than for below-median-
MAF (h2 ~ 0.23) SNPs among MGS ADs, although these
estimates were not significantly different from each other
and are consistent with random fluctuations in estimated
effects across models using different genomic-relationship
matrices.
On the other hand, we found no strong evidence sup-
porting the prediction that SNP-correlation estimates
would be higher in low-recombination regions (SNP-rg ¼
0.60, SE ¼ 0.27, p(SNP-rg ¼ 0) ¼ 0.008, p(SNP-rg ¼ 1) ¼ 0.28
between MGS ADs and MGS EDs and SNP-rg ¼ 0.70, SE ¼
0.25, p(SNP-rg ¼ 0) ¼ 0.0001, p(SNP-rg ¼ 1) ¼ 0.34 between
MGS ADs and ISC EDs) than in high-recombination
regions (SNP-rg ¼ 0.64, SE ¼ 0.23, p(SNP-rg ¼ 0) ¼ 0.0005,
p(SNP-rg ¼ 1) ¼ 0.23 between MGS ADs and MGS EDs and
SNP-rg¼ 0.41, SE¼ 0.20, p(SNP-rg ¼ 0)¼ 0.019, p(SNP-rg ¼ 1)¼
0.054 between MGS ADs and ISC EDs; Table 3).
Table 2. SNP-Heritability and SNP-Correlation Estimates from Bivariate Models
Sample 1 Sample 2 Sample 1 n Sample 2 n Sample 1 h2 (SE) Sample 2 h2 (SE) cov12
a SNP-rg (SE) p(SNP-rg ¼ 0) p(SNP-rg ¼ 1)
Across Ethnicity
MGS AD MGS ED 2,142 4,990 0.20 (0.09) 0.33 (0.03) 0.17 0.66 (0.23) 0.0003 0.26
MGS AD ISC ED 2,142 6,665 0.22 (0.09) 0.27 (0.02) 0.15 0.61 (0.21) 0.0003 0.16
Within Ethnicity
MGS ED ISC ED 4,990 6,665 0.26 (0.03) 0.27 (0.02) 0.22 0.83 (0.09) <0.0001 0.09
aCalculated by cov12 ¼ SNP-rgh1h2.
466 The American Journal of Human Genetics 93, 463–470, September 5, 2013
To examine whether some of the genetic overlap in
schizophrenia between ED and AD samples might be due
to the relatively high level of European admixture in
ADs, estimated to be an average of ~15%,26 we rederived
SNP-correlation estimates by using subsamples of ADs
with increasingly lower proportions of European ancestry
as judged from the first ancestry PC. We found modest
but nonsignificant decreases in SNP correlation between
ADs and EDs (Table 4). In particular, SNP-rg was estimated
to be 0.46 (se ¼ 0.26, p(SNP-rg ¼ 0) ¼ 0.064, p(SNP-rg ¼ 1) ¼
0.23) between the least admixed MGS ADs and MGS
EDs and to be 0.54 (se ¼ 0.24, p(SNP-rg ¼ 0) ¼ 0.006,
p(SNP-rg ¼ 1) ¼ 0.19) between the least admixed MGS ADs
and ISC EDs.
Discussion
Using the largest combined AD and ED schizophrenia
case-control GWAS available, we have demonstrated an
application that uses direct estimates of SNP correlations
to quantify the amount of shared genetic variance tagged
by SNPs between any two ethnically distinct populations
for any trait. We found that common genetic liability to
schizophrenia is largely shared across ED and primarily
AD populations. Because SNPs included in GWASs are un-
likely to tag the effects of rare causal variants and because
rarer causal variants are increasingly likely to be popula-
tion specific, these estimates of overlap are unlikely to
apply to the portion of schizophrenia heritability caused
by rare causal variants. Although we make no assertion
that all estimated gene effects are exactly additive, these
results are unlikely to be very biased by nonadditive
genetic effects because, if they exist, they contribute very
little to the similarity of distantly related individuals.
Even for comparisons of the same trait within an
ethnicity, SNP correlations between different samples are
typically less than 1 as a result of loss of real signal (e.g.,
greater ethnic, phenotypic, and environmental homoge-
neity within samples) and potential artifacts that can
inflate the unshared portions of heritability (e.g., SNP
calling or plate confounds that differ systematically
between cases and controls). Artifacts are expected to
deflate, not inflate, SNP correlations because random direc-
tional effects of artifacts are not expected to be consistent
across data sets. Because MGS ADs, MGS EDs, and ISC
EDs were all collected in different labs and genotyped on
separate plates, the SNP correlation between MGS EDs
and ISC EDs provides an upper limit on the potential
SNP correlation between MGS ADs and MGS or ISC EDs.
Given that SNP correlations between samples drawn
from the same population are expected to be 1 in the
absence of artifacts, we estimate that the SNP correlation
might be as high as approximately 0.75 (0.61/0.83 or
Table 3. SNP-Heritability and SNP-Correlation Estimates from Bivariate Models for SNP Bins Based on MAF and Recombination
Sample 1 Sample 2 Sample 1 n Sample 2 n Sample 1 h2 (SE) Sample 2 h2 (SE) cov12
a SNP-rg (SE) p(SNP-rg ¼ 0) p(SNP-rg ¼ 1)
High-MAF SNP Bin
MGS AD MGS ED 2,142 4,990 0.13 (0.07) 0.27 (0.03) 0.15 0.79 (0.28) <0.0001 0.52
MGS AD ISC ED 2,142 6,665 0.12 (0.07) 0.22 (0.02) 0.11 0.67 (0.27) 0.0004 0.37
MGS ED ISC ED 4,990 6,665 0.22 (0.03) 0.21 (0.02) 0.18 0.82 (0.09) <0.0001 0.0717
Low-MAF SNP Bin
MGS AD MGS ED 2,142 4,990 0.21 (0.09) 0.25 (0.02) 0.08 0.34 (0.20) 0.0706 0.0399
MGS AD ISC ED 2,142 6,665 0.24 (0.09) 0.22 (0.02) 0.10 0.42 (0.18) 0.0126 0.0321
MGS ED ISC ED 4,990 6,665 0.19 (0.03) 0.23 (0.02) 0.17 0.83 (0.12) <0.0001 0.19
High-Recombination SNP Bin
MGS AD MGS ED 2,142 4,990 0.20 (0.08) 0.28 (0.03) 0.15 0.64 (0.23) 0.0005 0.23
MGS AD ISC ED 2,142 6,665 0.20 (0.08) 0.22 (0.02) 0.09 0.41 (0.20) 0.0193 0.0541
MGS ED ISC ED 4,990 6,665 0.21 (0.03) 0.22 (0.02) 0.17 0.80 (0.11) <0.0001 0.0836
Low-Recombination SNP Bin
MGS AD MGS ED 2,142 4,990 0.13 (0.07) 0.23 (0.03) 0.10 0.60 (0.27) 0.0076 0.28
MGS AD ISC ED 2,142 6,665 0.15 (0.07) 0.21 (0.02) 0.12 0.70 (0.25) 0.0001 0.34
MGS ED ISC ED 4,990 6,665 0.19 (0.03) 0.20 (0.02) 0.17 0.86 (0.10) <0.0001 0.19
Estimates above are from independent analyses in which the following SNP bins were included separately for each model: 238,810 SNPs with high average MAF
across ADs and EDs, 238,854 SNPs with low average MAF across ADs and EDs, 238,352 SNPs in high-recombination regions, and 238,352 SNPs in low-recom-
bination regions. Recombination rates were estimated from CEU, YRI, and JPTþCHB HapMap populations, and high- and low-MAF and high- and low-recombi-
nation bins were formed with median splits of SNP MAFs and recombination rates, respectively. The Pearson correlation between SNP MAF and recombination
rate was 0.006 (p ¼ 0.0001).
aCalculated by cov12 ¼ SNP-rgh1h2.
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0.66/0.83) between EDs and ADs when corrected for
artifacts that lower genetic correlations. This SNP correla-
tion might be closer to 0.5 (0.46/0.83 or 0.54/0.83)
between nonadmixed AD and ED populations.
There are two principal reasons why genetic correlations
across ethnicities are expected to be lower than those
within ethnicities. First, some causal variants might have
different effects across ethnicities (e.g., because of differ-
ences in environmental or genetic backgrounds), and
some might be population specific if they arose or were
lost after the European-African divergence thought to
have occurred 50–100K years ago.28–30 Our finding that
high-MAF SNPs show greater SNP correlations than low-
MAF SNPs lends some support to the hypothesis that
lower-MAF schizophrenia causal variants are increasingly
population specific and/or are differentially tagged by
SNPs across ethnicities. Second, lower SNP correlations
should occur to the degree that LD between causal variants
and the SNPs that predict them differs across ethnicity.
However, we did not find strong evidence that SNP corre-
lations were lower for high-recombination regions than
for low-recombination regions, which might be expected
if differing LD patterns reduce the SNP correlation between
EDs and ADs. Nonetheless, our results do not allow us to
reliably quantify the relative importance of these two
alternatives.
Two limitations to our analysis are worth noting. First,
the AD sample size in particular was small, leading to large
SEs around estimates of both SNP heritabilities and SNP
correlations between ethnicities. This means that we
cannot place great confidence in the specific estimates of
SNP correlation, and we reiterate that these parameters
reflect the allelic spectrum captured by common SNPs
and so might not generalize to the covariance attributable
to variants in low LD with common SNPs. Nevertheless,
our results suggest that there is substantial overlap of vari-
ants tagged by common SNPs between ethnic groups (with
95% confidence that SNP-rg has a lower bound of 0.20) and
allow us to rule out the possibility of no overlap with even
greater confidence. Second, no AD replication GWAS data
set of sufficient size exists for this or any other psychiatric
disorder, highlighting the importance of further large-scale
genome-wide data collection in non-ED samples.
In summary, we have demonstrated how a random-
effects modeling approach fitting all SNPs simultaneously
can elucidate the degree to which additive genetic varia-
tion tagged by SNPs is shared between ethnically divergent
populations. We estimate that about half to three-quarters
of such additive genetic variation underlying the risk of
schizophrenia is shared between AD and ED populations,
suggesting that schizophrenia GWAS discoveries from
European samples are likely to be relevant to AD popula-
tions and thatmeta-analyses of schizophrenia can improve
power by including results across both ED and AD samples.
These conclusions should apply even more strongly to
other ethnic groups given their more recent divergence
times from the European lineage. Because it is vanishingly
unlikely that different causal variants between ethnicities
would systematically be in LD with the same SNPs, these
findings suggest that many schizophrenia causal variants
are ancient and predate European-African divergence.
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